Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Am J Physiol Gastrointest Liver Physiol ; 302(1): G105-15, 2012 Jan 01.
Artigo em Inglês | MEDLINE | ID: mdl-21921286

RESUMO

SAMP1/YitFcs mice serve as a model of Crohn's disease, and we have used them to assess gastritis. Gastritis was compared in SAMP1/YitFcs, AKR, and C57BL/6 mice by histology, immunohistochemistry, and flow cytometry. Gastric acid secretion was measured in ligated stomachs, while anti-parietal cell antibodies were assayed by immunofluorescence and enzyme-linked immunosorbent spot assay. SAMP1/YitFcs mice display a corpus-dominant, chronic gastritis with multifocal aggregates of mononuclear cells consisting of T and B lymphocytes. Relatively few aggregates were observed elsewhere in the stomach. The infiltrates in the oxyntic mucosa were associated with the loss of parietal cell mass. AKR mice, the founder strain of the SAMP1/YitFcs, also have gastritis, although they do not develop ileitis. Genetic studies using SAMP1/YitFcs-C57BL/6 congenic mice showed that the genetic regions regulating ileitis had comparable effects on gastritis. The majority of the cells in the aggregates expressed the T cell marker CD3 or the B cell marker B220. Adoptive transfer of SAMP1/YitFcs CD4(+) T helper cells, with or without B cells, into immunodeficient recipients induced a pangastritis and duodenitis. SAMP1/YitFcs and AKR mice manifest hypochlorhydria and anti-parietal cell antibodies. These data suggest that common genetic factors controlling gastroenteric disease in SAMP1/YitFcs mice regulate distinct pathogenic mechanisms causing inflammation in separate sites within the digestive tract.


Assuntos
Acloridria/imunologia , Doenças Autoimunes/imunologia , Gastrite/imunologia , Ileíte/imunologia , Acloridria/genética , Acloridria/patologia , Transferência Adotiva , Animais , Autoanticorpos/análise , Autoanticorpos/imunologia , Doenças Autoimunes/genética , Doenças Autoimunes/patologia , Linfócitos B/imunologia , Linfócitos B/patologia , Complexo CD3/análise , Complexo CD3/imunologia , Feminino , Ácido Gástrico/metabolismo , Gastrite/genética , Gastrite/patologia , Ileíte/genética , Ileíte/patologia , Antígenos Comuns de Leucócito/análise , Antígenos Comuns de Leucócito/imunologia , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Linfócitos T/imunologia , Linfócitos T/patologia , Linfócitos T Auxiliares-Indutores/imunologia
2.
Mucosal Immunol ; 2(3): 232-42, 2009 May.
Artigo em Inglês | MEDLINE | ID: mdl-19262506

RESUMO

Helicobacter pylori causes a lifelong infection and provides a model of bacterial adaptation and persistent colonization. Adenosine is an anti-inflammatory mediator that limits tissue damage during inflammation. We studied the role of adenosine in the T-cell-mediated regulation of gastritis and bacterial persistence. After 4 h of activation, human T helper (Th) cells increased A(2A) adenosine receptor (A(2A)AR) mRNA level (sevenfold). A(2A)AR was the predominant subtype expressed in resting and stimulated gastric or peripheral Th cells. Stimulation with ATL313, an A(2A)AR agonist, increased cyclic AMP (cAMP) accumulation and reduced interleukin-2 (IL-2) production by 20-50%. ATL313 also attenuated tumor necrosis factor-alpha (TNF-alpha) and interferon-gamma (IFN-gamma) production, which was inhibited by an A(2A)AR antagonist. Infection of IL-10-deficient mice with H. pylori is cleared spontaneously due to the marked inflammation. Administration of ATL313 during infection reduced gastritis and pro-inflammatory cytokine responses while bacterial load increased. In contrast, infection of A(2A)AR-deficient mice enhanced gastritis. Thus, A(2A)AR limits the pro-inflammatory effects of Th cells and favor chronic Helicobacter infection.


Assuntos
Citocinas/biossíntese , Mucosa Gástrica/imunologia , Gastrite/imunologia , Infecções por Helicobacter/imunologia , Receptor A2A de Adenosina/imunologia , Linfócitos T Auxiliares-Indutores/imunologia , Agonistas do Receptor A2 de Adenosina , Animais , Antígenos CD4/biossíntese , AMP Cíclico/metabolismo , Citocinas/imunologia , Mucosa Gástrica/efeitos dos fármacos , Mucosa Gástrica/microbiologia , Gastrite/tratamento farmacológico , Gastrite/microbiologia , Infecções por Helicobacter/tratamento farmacológico , Infecções por Helicobacter/microbiologia , Helicobacter felis , Helicobacter pylori , Humanos , Interferon gama/biossíntese , Interleucina-10/biossíntese , Interleucina-10/genética , Interleucina-2/biossíntese , Ativação Linfocitária , Camundongos , Camundongos Knockout , Piperidinas/farmacologia , Piperidinas/uso terapêutico , Receptor A2A de Adenosina/genética , Linfócitos T Auxiliares-Indutores/metabolismo , Fator de Necrose Tumoral alfa/biossíntese
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA